Overview of Dr. Andrews
Dr. Jinsy Andrews is a neurologist in New York, NY and is affiliated with multiple hospitals in the area, including New York-Presbyterian Hospital, NewYork-Presbyterian/Columbia University Irving Medical Center, and James J. Peters Veterans Affairs Medical Center. She received her medical degree from Albany Medical College and has been in practice 16 years. She is one of 474 doctors at New York-Presbyterian Hospital and one of 18 doctors at James J. Peters Veterans Affairs Medical Center who specialize in Neurology. She has more than 60 publications and over 500 citings.
Office
710 West 168th Street
New York, NY 10032
Education & Training
Columbia University Mailman School of Public HealthMSc, Biostatistics, 2007 - 2009
New York Presbyterian Hospital (Cornell Campus)Fellowship, Clinical Neurophysiology, 2006 - 2007- New York Presbyterian Hospital (Columbia Campus)Fellowship, Neuromuscular Medicine (Neurology), 2005 - 2006
University of ConnecticutResidency, Neurology, 2002 - 2005- University of ConnecticutInternship, Internal Medicine, 2001 - 2002
Albany Medical CollegeClass of 2001
Certifications & Licensure
CA State Medical License 2016 - 2026
NY State Medical License 2005 - 2026
NJ State Medical License 2021 - 2025
CT State Medical License 2010 - 2017
American Board of Psychiatry and Neurology Neurology- American Board of Psychiatry and Neurology Neuromuscular Medicine
Awards, Honors, & Recognition
- Fellow of the American Academy of Neurology American Academy of Neurology (AAN), 2018
- Diamond Award for ALS Research Wings Over Wall Street/MDA, 2009
Clinical Trials
- Study to Investigate the Safety and Efficacy of Lithium in Volunteers With Amyotrophic Lateral Sclerosis (ALS) Start of enrollment: 2009 Jan 01
- Ciprofloxacin/Celecoxib Combination in Patients With ALS Start of enrollment: 2019 Dec 09
Publications & Presentations
PubMed
- Verdiperstat in Amyotrophic Lateral Sclerosis: Results From the Randomized HEALEY ALS Platform Trial., Jinsy Andrews, Sabrina Paganoni, Eric A Macklin, Lori B Chibnik
JAMA Neurology. 2025-02-17 - 2 citationsCNM-Au8 in Amyotrophic Lateral Sclerosis: The HEALEY ALS Platform Trial., James D Berry, Nicholas J Maragakis, Eric A Macklin, Lori B Chibnik
JAMA. 2025-02-17 - Pridopidine in Amyotrophic Lateral Sclerosis: The HEALEY ALS Platform Trial., Jeremy M Shefner, Björn Oskarsson, Eric A Macklin, Lori B Chibnik
JAMA. 2025-02-17
Press Mentions
ProJenX Announces Formation of Clinical Advisory BoardAugust 27th, 2024- New ALS Drug Relyvrio Approved by FDA: The Debate over Its EffectivenessSeptember 30th, 2022
- New Drugs for ALS and Alzheimer’s Show Great PromiseSeptember 30th, 2022
- Join now to see all
Grant Support
- Intermediate-sized Expanded Access Protocol for CNM-Au8 in Amyotrophic Lateral Sclerosis (ALS).COLUMBIA UNIVERSITY HEALTH SCIENCES2023–2027
- Intermediate-sized Expanded Access Protocol for CNM-Au8 in Amyotrophic Lateral Sclerosis (ALS).COLUMBIA UNIVERSITY HEALTH SCIENCES2023–2027
- Intermediate-sized Expanded Access Protocol for CNM-Au8 in Amyotrophic Lateral Sclerosis (ALS).COLUMBIA UNIVERSITY HEALTH SCIENCES2023–2027
- Intermediate-sized Expanded Access Protocol for CNM-Au8 in Amyotrophic Lateral Sclerosis (ALS).COLUMBIA UNIVERSITY HEALTH SCIENCES2023–2027
- Access for All in ALS (ALL ALS) East Clinical Coordinating CenterMASSACHUSETTS GENERAL HOSPITAL2023–2025
- Access for All in ALS (ALL ALS) East Clinical Coordinating CenterMASSACHUSETTS GENERAL HOSPITAL2023–2025
- Access for All in ALS (ALL ALS) East Clinical Coordinating CenterMASSACHUSETTS GENERAL HOSPITAL2023–2025
- Access for All in ALS (ALL ALS) East Clinical Coordinating CenterMASSACHUSETTS GENERAL HOSPITAL2023–2025
- Access for All in ALS (ALL ALS) East Clinical Coordinating CenterMASSACHUSETTS GENERAL HOSPITAL2023–2025
- Access for All in ALS (ALL ALS) East Clinical Coordinating CenterMASSACHUSETTS GENERAL HOSPITAL2023–2025
Professional Memberships
- Fellow
- Member
- American Neurological Association - ANAFellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
